TotalMarketCap

Arcturus Therapeutics

ARCTNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$266.864 M

$9.39 -13.63%

Close of 6 Nov 2026

As of 6 Nov 2026, Arcturus Therapeutics (ARCT) has a market capitalization of $266.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$82.0M

#2552 by revenue

Earnings

-$65.8M

Loss-making

Shares outstanding

28,822,514

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #224Turn TherapeuticsTTRX$272.7M
  2. #225Rocket PharmaceuticalsRCKT$267.3M
  3. #226Arcturus TherapeuticsARCT$266.9M
  4. #227Cypherpunk TechnologiesCYPH$265.6M
  5. #228Q32 BioQTTB$265.1M

What if Arcturus Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$993,449.15

Per share 105,810× higher

Bitcoin $1.53T

$53,753.80

Per share 5,725× higher

Apple $5.02T

$176,468.72

Per share 18,795× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Arcturus Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.